Clinical Scorecard: Combining Mucosal Advancement Flap and Platelet-Rich Plasma for Managing High Perianal Fistulas in Crohn’s Disease: A Preliminary Investigation

At a Glance

Key Highlights

• HPFs in Crohn’s disease have lower healing rates with conventional surgery alone (40–50% with MAF).
• PRP contains multiple growth factors that may improve wound healing beyond fibrin glue.
• In a pilot study of 10 patients, 80% achieved fistula healing with MAF combined with PRP, median healing time 52.5 days.

Guideline-Based Recommendations

Diagnosis

• Clinical examination and MRI to confirm and classify high perianal fistulas.
• Exclude recto-vaginal fistulas and active proctitis before surgery.

Management

• Initial treatment with non-cutting seton for at least 3 months to drain sepsis and reduce inflammation.
• Ensure luminal Crohn’s disease is in clinical and endoscopic remission before surgery.
• Use thiopurines with antibiotics as first-line medical therapy; anti-TNF agents (infliximab, adalimumab) as second-line.
• Combine anti-TNF treatment with ciprofloxacin to improve outcomes.
• Perform mucosal advancement flap surgery combined with PRP injection into fistula tract after seton treatment.

Monitoring & Follow-up

• Follow-up visits at 6 weeks, 3 months, 6 months, and 1 year postoperatively.
• Assess fistula healing clinically and by MRI if closure is uncertain.
• Evaluate continence status using Vaizey score at end of follow-up.
• Contact patients by phone if lost to follow-up to assess fistula status.

Risks

• Recurrence of fistula after initial healing (noted in 10% of healed patients in study).
• Delayed healing may occur (up to 114 days reported).
• Avoid surgery if active proctitis is present to reduce failure risk.

Patient & Prescribing Data

Ten consecutive patients with primary or recurrent Crohn’s disease-related high perianal fistulas, median age 47.5 years, 70% female.

80% healing rate observed with MAF plus PRP after prior seton drainage; one recurrence reported; corticosteroids tapered before surgery.

Clinical Best Practices

• Confirm fistula anatomy and activity status with MRI before intervention.
• Ensure luminal Crohn’s disease remission prior to surgical treatment.
• Use non-cutting seton drainage for at least 3 months before definitive surgery.
• Prepare PRP from patient’s own blood with 6–8 times platelet concentration and activate with thrombin during injection.
• Perform mucosal advancement flap combined with PRP injection into fistula tract to enhance healing.
• Monitor patients closely postoperatively with scheduled visits and imaging as needed.
• Assess continence outcomes systematically using validated scoring.

References

• European Crohn and Colitis Organisation (ECCO) guidelines for complex perianal fistula
• Previous study on MAF combined with PRP for high cryptoglandular perianal fistulas